E-LIB Suche - Ergebnisse für: Oliveira Ascef, Bruna - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Methodological guidelines and publications of benefit–risk ..:

Suzumura, Erica Aranha ; de Oliveira Ascef, Bruna ; Maia, Fernando Henrique de Albuquerque...
BMJ Open. 14 (2024) 6 - p. e086603 , 2024

Link: https://doi.org/10.1136/..

2

Methodological guidelines and publications of benefit–risk ..:

De Oliveira Ascef, Bruna ; Gabriel, Franciele Cordeiro ; Suzumura, Erica Aranha...
BMJ Open. 13 (2023) 12 - p. e075333 , 2023

Link: https://doi.org/10.1136/..

3

Impact of switching between reference biologics and biosimi..:

de Oliveira Ascef, Bruna ; Almeida, Matheus Oliveira ; de Medeiros-Ribeiro, Ana Cristina...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

Forecasting models for leprosy cases: a scoping review prot..:

Oliveira Ascef, Bruna ; de Oliveira, Gustavo Laine Araújo ; Ribeiro Filha Coriolano, Carmelita.
BMJ Open. 12 (2022) 7 - p. e062828 , 2022

Link: https://doi.org/10.1136/..

5

Health technology assessment of biosimilars worldwide: a sc..:

Ascef, Bruna de Oliveira ; Lopes, Ana Carolina de Freitas ; de Soárez, Patrícia Coelho
Health Research Policy and Systems. 18 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

6

Methodological guidelines and publications of benefit–risk ..:

De Oliveira Ascef, Bruna ; Gabriel, Franciele Cordeiro ; Suzumura, Erica Aranha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10729267/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Impact of switching between reference biologics and biosimi..:

de Oliveira Ascef, Bruna ; Almeida, Matheus Oliveira ; de Medeiros-Ribeiro, Ana Cristina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444768/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Forecasting models for leprosy cases: a scoping review prot..:

Oliveira Ascef, Bruna ; de Oliveira, Gustavo Laine Araújo ; Ribeiro Filha Coriolano, Carmelita.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341210/. , 2022

Link: http://www.ncbi.nlm.nih...

9

Impact of switching between reference biologics and biosimi..:

Bruna de Oliveira Ascef ; Matheus Oliveira Almeida ; Ana Cristina de Medeiros-Ribeiro...
https://doi.org/10.1038/s41598-023-40222-5. , 2023

Link: https://doi.org/10.1038/..

10

Methodological guidelines and publications of benefit–risk ..:

Patricia Coelho De Soárez ; Uwe Siebert ; Franciele Cordeiro Gabriel...
https://bmjopen.bmj.com/content/13/12/e075333.full. , 2023

Link: https://doi.org/10.1136/..

11

Therapeutic Equivalence of Biosimilar and Reference Biologi..:

Ascef, Bruna de Oliveira ; Almeida, Matheus Oliveira ; de Medeiros-Ribeiro, Ana Cristina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220520/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Forecasting models for leprosy cases: a scoping review prot..:

Bruna Oliveira Ascef ; Gustavo Laine Araújo de Oliveira ; Carmelita Ribeiro Filha Coriolano.
https://bmjopen.bmj.com/content/12/7/e062828.full. , 2022

Link: https://doi.org/10.1136/..

13

Equivalence and switching between biosimilars and reference..:

Ascef, Bruna O. ; Almeida, Matheus O. ; de Medeiros Ribeiro, Ana Cristina...
Systematic Reviews. 10 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

14

Health technology assessment of biosimilars worldwide: a sc..:

Ascef, Bruna de Oliveira ; Lopes, Ana Carolina de Freitas ; de Soárez, Patrícia Coelho
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448328/. , 2020

Link: http://www.ncbi.nlm.nih...

15

Health technology assessment of biosimilars worldwide: a sc..:

Bruna de Oliveira Ascef ; Ana Carolina de Freitas Lopes ; Patrícia Coelho de Soárez
http://link.springer.com/article/10.1186/s12961-020-00611-y. , 2020

Link: https://doi.org/10.1186/..

1-15